Business Context and Reporting Period
This Form 8-K filing by KBL Merger Corp. IV (the "Company") reports events occurring on June 7, 2017, with the report dated June 13, 2017. The Company is a Delaware corporation and an emerging growth company. The filing details the consummation of its Initial Public Offering (IPO) and a concurrent private placement.
Key Financial Metrics
- IPO Gross Proceeds: $100,000,000 from the sale of 10,000,000 Units at $10.00 per Unit.
- Private Placement Proceeds: $4,500,000 from the sale of 450,000 placement units.
- Total Funds Deposited in Trust: $101,000,000.
- Over-Allotment Option: Underwriters granted a 45-day option to purchase up to 1,500,000 additional Units.
- Unit Composition: Each Unit consists of one share of Common Stock, one right (entitling the holder to 1/10 of a share upon business combination), and one warrant (to purchase 1/2 of a share).
Note: As this is an IPO filing, traditional operating metrics such as revenue, profit, cash flow from operations, and margins are not applicable. The filing text does not provide data on debt or liquidity beyond the trust account balance.
Material Changes
The primary material change is the transition from a private entity to a publicly traded company following the IPO. The Company has raised significant capital, with $101,000,000 secured in a trust account for the benefit of public stockholders. An audited balance sheet as of June 7, 2017, reflecting these proceeds, is included as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance or operational outlook as the Company is a special purpose acquisition company (SPAC) seeking an initial business combination. The primary contingency is the potential exercise of the underwriters' over-allotment option within 45 days. The rights included in the Units are contingent upon the consummation of an initial business combination.
Investor Verification Checklist
- Verify the final audited balance sheet (Exhibit 99.1) to confirm the exact cash position and any transaction costs deducted from the gross proceeds.
- Confirm the terms of the rights and warrants, specifically the exercise price and expiration dates, which are not detailed in this summary text.
- Monitor the status of the 45-day over-allotment option to determine if the total capital raised will exceed the initial $104.5 million.
- Review the trust account agreement to understand the conditions under which funds may be withdrawn prior to a business combination.